Results 201 to 210 of about 71,654 (260)
Some of the next articles are maybe not open access.
Psoralen and Ultraviolet A Light Therapy for Psoriasis
New England Journal of Medicine, 2007A 52-year-old man with psoriasis seeks treatment for his skin condition. Treatment with psoralen and ultraviolet A (PUVA) is recommended.
Robert Stern, Stern Robert S
exaly +3 more sources
Bath psoralen-ultraviolet A therapy in atopic eczema
Journal of the European Academy of Dermatology and Venereology, 2000AbstractAims To evaluate the efficacy of bath psoralen‐ultraviolet A (PUVA) therapy in severe cases of atopic dermatitis (AD) in adults using the extended Six Area, Six Sign Atopic Dermatitis (SASSAD) score.Methods Thirty‐five adult subjects with severe AD underwent bath PUVA therapy for a maximum of 30 sessions ranging from one to three times a week ...
W J, de Kort, H, van Weelden
exaly +3 more sources
Lupus, 2001
This review examines the use of ultraviolet (UV) therapy in lupus erythematosus (LE), a disorder usually associated with abnormally increased photosensitivity. In addition to the abnormal cutaneous response to ultraviolet radiation (UVR) exposure, photo-aggravation of systemic disease activity in systemic LE (SLE) may also occur.
Millard, T P, Hawk, J L M
openaire +2 more sources
This review examines the use of ultraviolet (UV) therapy in lupus erythematosus (LE), a disorder usually associated with abnormally increased photosensitivity. In addition to the abnormal cutaneous response to ultraviolet radiation (UVR) exposure, photo-aggravation of systemic disease activity in systemic LE (SLE) may also occur.
Millard, T P, Hawk, J L M
openaire +2 more sources
Status of ultraviolet A dosimetry in methoxsalen plus ultraviolet A therapy
Journal of the American Academy of Dermatology, 1986The carcinogenic risk of methoxsalen plus ultraviolet A treatment (PUVA) is almost certainly related to the cumulative UVA exposure dose. A reliable estimate of UVA dose is a major component, therefore, in determining the long-term safety of this treatment modality.
B L, Diffey, R, Roelandts
openaire +2 more sources
Psoralens and ultraviolet A therapy of pityriasis lichenoides
Journal of the American Academy of Dermatology, 1984Three patients with long-standing pityriasis lichenoides, which was resistant to other forms of therapy, were successfully treated with PUVA (psoralens and ultraviolet light of wavelength A). One patient had complete clearing of all lesions, and the other two had marked improvement.
F C, Powell, S A, Muller
openaire +2 more sources
Ultraviolet Therapy for Psoriasis
2014Total-body ultraviolet therapy (UV) for moderate-to-severe psoriasis consists of narrowband and broadband-UVB, psoralen plus UVA (PUVA – where psoralen can be ingested orally or applied topically), inpatient phototherapy (i.e. Goeckerman Therapy, Ingram therapy), non-office-based phototherapy (i.e.
Tien V. Nguyen, John Y. M. Koo
openaire +1 more source
2008
Natural sunlight’s beneficial effect on psoriasis has been long known. This observation led over the past century to the utilization of artificial light sources for the treatment of psoriasis. For over seven decades, phototherapy using artificial ultraviolet light has been an established standard in the treatment of psoriasis.
Rahat S. Azfar, Abby S. Van Voorhees
openaire +1 more source
Natural sunlight’s beneficial effect on psoriasis has been long known. This observation led over the past century to the utilization of artificial light sources for the treatment of psoriasis. For over seven decades, phototherapy using artificial ultraviolet light has been an established standard in the treatment of psoriasis.
Rahat S. Azfar, Abby S. Van Voorhees
openaire +1 more source
Ultraviolet Therapy of Atopic Eczema
1997Recent results from a pilot study have suggested that irradiation of patients with high doses of ultraviolet A1 radiation (UVA-1; 340–400 nm) may be effectively used as a monotherapy in the management of severe exacerbation of atopic dermatitis [1]. This assumption has recently been confirmed in a multicenter trial [2].
J. Krutman, M. Grewe
openaire +1 more source

